Esperion Therapeutics (ESPR)
(Real Time Quote from BATS)
$2.40 USD
+0.28 (13.21%)
Updated May 7, 2024 03:55 PM ET
After-Market: $2.37 -0.03 (-1.25%) 4:10 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: BMO |
6/2024 | $-0.23 | 0.00% |
Earnings Summary
For their last quarter, Esperion Therapeutics (ESPR) reported earnings of $0.34 per share, beating the Zacks Consensus Estimate of $-0.08 per share. This reflects a positive earnings surprise of 525.00%. Look out for ESPR's next earnings release expected on August 06, 2024. For the next earning release, we expect the company to report earnings of -$0.23 per share, reflecting a year-over-year increase of 78.48%.
Earnings History
Price & Consensus
Zacks News for ESPR
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
ESPR: What are Zacks experts saying now?
Zacks Private Portfolio Services